| ADHERE | Acute Decompensated Heart Failure National Registry |
| AHF | Acute heart failure |
| ALARM-HF | Acute Heart Failure Global Registry of Standard Treatment |
| BNP | B-type natriuretic peptide |
| cIV | Continuous intravenous infusion |
| CKD | Chronic kidney disease |
| DOSE | Diuretic strategies in acute decompensated heart failure |
| DR | Diuretic response |
| eGFR | Estimated glomerular filtration rate; |
| ESCAPE | Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness |
| HD | High dose |
| HF | Heart failure |
| iIV | Intermittent intravenous infusion |
| IQR | Interquartile range |
| IV | Intravenous |
| LD | Low dose |
| MDRD | Modification of diet in renal disease |
| PROTECT | Placebo-controlled randomized study of the selective A(1) adenosine receptor antagonist rolofylline |
| RELAX-AHF | Relaxin in acute heart failure |
| ROC | Receiving operating characteristics |
| WRF | Worsening renal function |